Adamis Pharmaceuticals Corporation (ADMP)

NASDAQ: ADMP · Delayed Price · USD
0.461
0.014 (3.18%)
At close: May 27, 2022 4:00 PM
0.450
-0.011 (-2.386%)
After-hours:May 27, 2022 5:20 PM EDT

Ratios and Metrics (Annual)

Millions USD. Fiscal year is Jan - Dec.
YearCurrent20212020201920182017201620152013201220112010 - 1995
Market Capitalization
699045431061476873676922
Upgrade
Market Cap Growth
-98.26%5.25%-59.43%-27.57%116.06%-6.26%8.92%-3.39%214.99%-
Upgrade
Enterprise Value
52684338901347068627022
Upgrade
PE Ratio
--1.97-0.92-1.57-2.73-5.75-3.27-5.34-8.16-9.58-4.45
Upgrade
PS Ratio
14.4840.7816.361.957.0511.2410.50----
Upgrade
PB Ratio
4.343.4812.991.312.283.722.697.795.46-15.92-8.03
Upgrade
EV/Sales Ratio
10.8828.1114.381.605.119.7710.33----
Upgrade
EV/EBITDA Ratio
--------81.78--
Upgrade
EV/EBIT Ratio
--------133.27--
Upgrade
Debt / Equity Ratio
0.040.031.200.120.060.130.2900.03-0.27-0.11
Upgrade
Debt / EBITDA Ratio
-0.02-0.02-0.09-0.17-0.07-0.22-0.3500.55-0.24-0.06
Upgrade
Debt / FCF Ratio
-0.01-0.02-0.20-0.18-0.07-0.29-0.350-0.06-0.46-0.09
Upgrade
Current Ratio
2.053.140.631.482.232.440.821.511.850.080.01
Upgrade
Asset Turnover
0.110.040.070.440.280.280.220000
Upgrade
Return on Equity (ROE)
-132.80%-113.00%-226.50%-74.90%-95.50%-72.80%-112.80%-100.10%-263.60%170.40%239.60%
Upgrade
Return on Assets (ROA)
-91.90%-80.50%-123.70%-54.90%-73.70%-55.10%-71.40%-85.40%-87.00%-750.70%-1314.60%
Upgrade
Return on Capital (ROIC)
-695.50%-687.90%-444.60%-175.80%-491.60%-421.60%-1049.80%649.10%-12.30%171.00%250.40%
Upgrade
Earnings Yield
-59.11%-50.88%-108.71%-63.73%-36.66%-17.39%-30.61%-18.71%-12.25%-10.44%-22.46%
Upgrade
FCF Yield
-59.51%-43.31%-47.00%-52.71%-34.01%-11.71%-31.30%-14.25%-10.33%-3.71%-15.29%
Upgrade
Buyback Yield / Dilution
-15.57%-85.84%-45.63%-36.27%-37.87%-61.99%-30.25%-79.32%-27.89%-11.31%-40.28%
Upgrade
Total Shareholder Return
-15.57%-85.84%-45.63%-36.27%-37.87%-61.99%-30.25%-79.32%-27.89%-11.31%-40.28%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).